Annovis Bio (NYSE:ANVS) Stock

Annovis Bio

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Biotech

Earnings

Earnings Misses

News

Penny Stocks

Small Cap

Markets

Analyst Ratings

Trading Ideas

General

AKRO

ANVS

EDIT

VRTX

Editas Medicine, Inc. (NASDAQ: EDIT) incurred a loss of 82 cents per share in the second quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 69 cents. The company had reported a loss of 56 cents per share in the year-ago quarter.

Editas Q2 Earnings &amp; Revenues Miss Estimates, Stock Down

Earnings Beats

ARQT

IMMP

Immutep Limited (NASDAQ: IMMP) jumped 14.9% after it announced positive results from cohort B of the late-stage TACTI-003 (KEYNOTE-PNC-34) study.

Immutep Up as Combo Therapy Meets Carcinoma Study Goals

Costco.Shutterstock

Price Target

ASTH

BROS

CAVA

COST

LNTH

MCHP

TASK

Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday

Annovis Bio Inc

Press Releases

Annovis to Host Year-End Investor Webcast on December 11, 2024

Entertainment

/C O R R E C T I O N -- Today's Marketplace/

Annovis CEO Showcases Groundbreaking Advances in Neurodegenerative Disease Treatment on Today's Marketplace

Health Care

FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer's Disease Study, Streamlining Development Pathway

Annovis Granted U.S. Patent for Treatment and Prevention of Acute Brain or Nerve Injuries Securing Global Protection

Annovis Bio, Inc. Announces Proposed Public Offering

Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering

Annovis Bio, Inc. Announces Closing of $21 Million Public Offering

Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer's Disease

Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Abpro Hldgs

Achilles Therapeutics plc - American Depositary Shares

Achilles Therapeutics

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

bluebird bio

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Celularity

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Hldgs

FibroBiologics

Generation Bio

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

Immix Biopharma

Immuneering Corporation - Class A Common Stock

Immuneering

IO Biotech

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Kala Bio

Kronos Bio

Lantern Pharma

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Repare Therapeutics

Shattuck Labs

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

D. Boral Capital

HC Wainwright & Co.

Maxim Group

EF Hutton

Rodman & Renshaw

Comments

Annovis Bio

Loading...

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga